RxDoctor Payments Data

Anthony Ngo, DO

Family Medicine · Clearwater, FLNPI 1033316815

Payments from drug & device makers

$1,451in general payments, 2019–2025

Across 43 payments — averaging $33.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$758
  • Regeneron Healthcare Solutions, Inc.$125
  • Novo Nordisk$87
  • Medtronic$71
  • Amgen$68
  • Exact Sciences$62
  • plus $279 from 9 others

What the payments were for

  • Food & beverage$1,451100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,451 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$80,753
Medicare patients
186
Services billed
1,808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$60,508
OzempicSemaglutide50$57,886
XareltoRivaroxaban47$47,610
JanuviaSitagliptin Phosphate33$41,987
JardianceEmpagliflozin24$30,910
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$26,274
Spiriva HandihalerTiotropium Bromide24$13,569
SymbicortBudesonide/Formoterol Fumarate33$11,824
Fluticasone-SalmeterolFluticasone Propion/Salmeterol67$10,462
VascepaIcosapent Ethyl17$9,111
Albuterol Sulfate HfaAlbuterol Sulfate159$5,885
Atorvastatin Calcium881$5,684
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,134
Omega-3 Acid Ethyl Esters36$4,373
Gabapentin153$3,189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$40$60,50850 claims
Novo NordiskOzempic$87$57,88650 claims
Boehringer IngelheimJardiance$39$30,91024 claims
GSKTrelegy Ellipta$758$26,27437 claims
AstraZenecaSymbicort$20$11,82433 claims
AbbVieSynthroid$42$78611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →